Latest Breaking News On - Group study to evaluate efficacy - Page 1 : comparemela.com

/PRNewswire/ Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced three presentations on amyotrophic lateral sclerosis (ALS) as part of the 2023.

United statesNew jerseySouth koreaJersey cityGustavoa suarez zambranoMalgorzata ciepielewskaOptum clinformaticsAlejandro salahJamesd berryMuscular dystrophy associationMitsubishi chemical groupMitsubishi tanabe pharma america incMitsubishi tanabe pharma corporationPrnewswire mitsubishi tanabe pharma america incDrug administrationGroup study to evaluate efficacy